Patent ID: 7642262
Filing Date: 2010-01-05
Classification: A61P,C07C,C07D,Y02P

Abstract:
1. A method for the alleviation or treatment of symptoms due to neurodegenerative diseases which are selected from the group consisting of Parkinson's disease and amyotrophic lateral sclerosis comprising administering to a patient in need of such alleviation or treatment an effective amount of a pharmaceutical composition containing, as an effective ingredient, a compound having the formula (I) or its pharmaceutically acceptable salt, hydrate, or hydrate salt: wherein R R E E A represents a nitrogen atom, X represents a hydrogen atom, a halogen atom, an alkoxy group, an alkyl group, or an alkyl group substituted with a halogen atom, and Q represents a phenyl group, a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, a hydroxyl group, a C and a carrier therefor.